Newest
PEBO ▼ sold $76K · Augenstein Mark filed 1d agoBBT ▲ bought $105K · Hollister Thomas J filed 2d agoBBT ▼ sold $20K · Eagan John Buckley filed 2d agoGS ▼ sold $60K · LESLIE ERICKA T filed 2d agoGS ▼ sold $163K · LESLIE ERICKA T filed 2d agoMSCI ▼ sold $1.5M · Gutowski Robert J. filed 2d agoGL ▼ sold $2.2M · MAJORS MICHAEL CLAY filed 2d agoPHR ▲ bought $362 · Linetsky David filed 2d agoPHR ▲ bought $320 · Linetsky David filed 2d agoRVI ▲ bought $23K · Whitney Meredith filed 2d agoLEO ▲ bought $369K · Saba Capital Management, L.P. filed 2d agoPG ▼ sold $5.7M · Jejurikar Shailesh filed 2d agoICLR ▼ sold $10K · Lyons Emer filed 2d agoICLR ▼ sold $10K · Lyons Emer filed 2d agoICLR ▼ sold $8K · Lyons Emer filed 2d agoICLR ▼ sold $15K · Lyons Emer filed 2d agoICLR ▼ sold $8K · Lyons Emer filed 2d agoPG ▼ sold $698K · Gama Paul filed 2d ago

Company / CIK 0001661460

Poseida Therapeutics, Inc.

Ticker
PSTX
Insiders on file
1
Federal contracts on record
none matched
Lobbying filings on record
none matched
SEC filings
EDGAR ↗
Latest trade on record
July 14, 2020

Poseida Therapeutics, Inc. (PSTX) has 1 insider on file who disclosed 0 transactions in the last 12 months (0 open-market buys, 0 sales, about $0 at reported prices). No federal contract award that started in the last 180 days was found for a recipient with exactly this name; no lobbying filing names it as client this year.

Last updated July 16, 2020 · Sources: SEC EDGAR; USAspending; Senate LDA

0

Insiders

NameRoleRowsBoughtSoldLast filed
NOVARTIS PHARMA AGInsider200July 16, 2020

Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.

Insider transactions

Download CSV2 rows · 978 bytes · insider and congressional rows for this ticker · all downloads

FilerSecuritySideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
NOVARTIS PHARMA AGPSTXExchange CJuly 14, 2020July 16, 20202d7,367,387——derivativeForm 4 ↗
NOVARTIS PHARMA AGPSTXExchange CJuly 14, 2020July 16, 20202d5,908,089——Form 4 ↗

Federal contracts (USAspending, awards started in the last 180 days)

No contract award starting in the last 180 days was found for a recipient named exactly "Poseida Therapeutics, Inc.". Subsidiaries and differently-spelled recipients are not matched — search contracts.

Lobbying (Senate LDA, as client)

No LDA filing posted since October 2025 names "Poseida Therapeutics, Inc." as the client. Filings under a subsidiary or trade-association name are not matched — search lobbying.

Guides for this page

Sources and method

Official sources behind this page
SourceFilingsRowsFirst filedNewest filedRead the originals
SEC EDGAR, Form 412July 16, 2020July 16, 2020Form 4 list on EDGAR

Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.

Not investment advice. Public records shown as filed; no recommendation is made or implied.